everolimus

Miscellaneous compounds - Everolimus is currently used as an immunosuppressant to prevent rejection of organ transplants. It is a derivative of Rapamycin, and works similarly to Rapamycin as an mTOR inhibitor. Reference standards of Everolimus API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => 2-((tert-Butyldimethylsilyl)oxy)ethyl 2,2,2-trichloroacetimidate
    [catalogue_number] => PA 05 73530
    [category_ids] => ,84,
    [chemical_name] => 
    [weight] => 320.72
    [form] => C10H20Cl3NO2Si
    [cas] => NA
    [pslug] => 2-tert-butyldimethylsilyl-oxy-ethyl-2-2-2-trichloroacetimidate-pa0573530
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 05 73530
PA 05 73530

2-((tert-Butyldimethylsilyl)oxy)ethyl 2,2,2-trichloroacetimidate


  • Catalogue No.:PA 05 73530

  • CAS :

    NA

  • Molecular Formula : C10H20Cl3NO2Si

  • Molecular Weight : 320.72

pharmaffiliates